Your browser doesn't support javascript.
loading
[A Case of Nivolumab Responding to Multiple Lymph Node Metastases during Multidisciplinary Treatment for Esophageal Cancer].
Gan To Kagaku Ryoho ; 49(13): 1995-1997, 2022 Dec.
Article en Ja | MEDLINE | ID: mdl-36733069
In nivolumab therapy for unresectable advanced esophageal cancer, there are a few cases that show a complete response, and long-term survival can be expected in such cases. Here, we report a case in which nivolumab had a complete response to multiple lymph node metastases during multidisciplinary treatment for esophageal cancer and survived for a relatively long period despite being elderly. Examination of complete response cases provides us with significant insights in considering the unexplained biomarkers of immune checkpoint inhibitors and treatment discontinuation during complete response.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Nivolumab Límite: Aged / Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2022 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Nivolumab Límite: Aged / Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2022 Tipo del documento: Article